Lakewood-Amedex Biotherapeutics INC. (LABT) — S-1/A Filings
All S-1/A filings from Lakewood-Amedex Biotherapeutics INC.. Browse 2 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (2)
-
Lakewood-Amedex Biotherapeutics Files S-1/A Amendment
— Apr 6, 2026 Risk: medium
Lakewood-Amedex Biotherapeutics Inc. filed an S-1/A amendment on April 6, 2026, to register securities. The filing includes various exhibits such as consents of -
Lakewood-Amedex Pursues Nasdaq Direct Listing, Raises $7.5M in Private Placement
— Apr 1, 2026 Risk: high
Lakewood-Amedex Biotherapeutics Inc. (LABT) is pursuing a direct listing on the Nasdaq Capital Market for 4,689,177 shares of common stock, with no firm-commitm
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX